1/5
FIEO Registered FIEO Registered Export Ready

Paclitaxel Protein Bound Particles 100 mg Injection

Sold by mba pharmaceuticals pvt ltd · Manufacturer, Brand Owner, Distributor, Exporter, Wholesaler · New Delhi, Delhi, India

Price
Price on request
In stock
Minimum order: 1 Centimetre

Export Snapshot

MOQ
1 Centimetre
Lead time
On request
Packaging
Standard export packaging
Shelf life / longevity
As per product specification
HS Code
940290
Origin
India
Port of dispatch
On request
Export markets served
Canada flag CA Colombia flag CO Ecuador flag EC Greece flag GR India flag IN +12 others
Values shown are for mba pharmaceuticals pvt ltd.
Compliance & Certifications
FIEO Registered FIEO Registered
Suitable for

Treatment of cancer

Know your supplier

mba pharmaceuticals pvt ltd is a Manufacturer, Brand Owner, Distributor, Exporter, Wholesaler based in New Delhi Delhi India.

New Delhi Dispatch on request FIEO member
mba pharmaceuticals pvt ltd logo

Manufacturer, Brand Owner, Distributor, Exporter, Wholesaler · New Delhi, Delhi, India

MBA Pharmaceuticals Pvt Ltd is a global pharmaceutical company with corporate origins in India. We manufacture, export and wholesale Oncology, Hepatitis- C, Nephrology, Vaccines, Rheumatic, Branded & Generic medicines. We export to more than 50 countries largely to the European Union(EU), MENA, Asia and CIS countries.

Registered address: New Delhi, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.

Established
2014
Employees
11–30
GST
07AAJCM1075D1ZO
IEC code
0514009446
Export markets
Canada flag CA Colombia flag CO Ecuador flag EC Greece flag GR India flag IN +12 others
GlobalLinker Member Since
Jul 2020
Turnover
250000001 - 500000000.
Incorporation Type
On request
Product details

What are the specifications of this product?

Overview

Mejopac 100 – Paclitaxel Protein Bound Particles 100 mg Composition : Paclitaxel Protein Bound Particles Suspension for Injection 100 mg Dosage Form: Injection Packing: 1 Vial Market Authorization: MBA Pharmaceuticals Pvt Ltd Country of Origin: India Store below 30°C

Product Description

Mejopac 100 – Paclitaxel Protein Bound Particles Suspension for Injection is an anti-cancer medication used in the treatment of breast cancer, pancreatic cancer, and non-small cell lung cancer.


This medication is administered as an injection by a qualified healthcare professional. Your doctor will determine the appropriate dosage and frequency based on your specific condition, which may be adjusted over time. It is crucial to follow your doctor’s instructions precisely. Taking this medication incorrectly or in excessive amounts can lead to serious side effects. It may take several weeks or months to notice the benefits, so continue with the treatment unless advised otherwise by your doctor.

Common side effects of Mejopac – Paclitaxel Protein Bound Particles include nausea, vomiting, and weakness. Serious side effects may also occur, such as swelling of the hands and lips, hair loss, and weight gain. To manage these side effects, your doctor may prescribe additional medication. However, if you notice symptoms such as unexplained bruising or bleeding, a sore throat, mouth ulcers, or a high temperature (fever), inform your doctor immediately. This medication may lower the number of red and white blood cells in your body, increasing your susceptibility to infections. Regular blood tests are necessary to monitor your blood cell count and liver function.

Before starting this treatment, inform your doctor if you have heart disease, liver or kidney problems, or if you are taking any medications for infections. Mejopac – Paclitaxel Protein Bound Particles can interact with other medications, so it is important to inform your healthcare team about all the medicines you are taking. This medication is not recommended during pregnancy or while breastfeeding. Both males and females should use effective contraception during treatment to prevent pregnancy.


Uses of Mejopac 100 – Paclitaxel Protein Bound Particles Suspension for Injection


Breast Cancer

Non-Small Cell Lung Cancer

Pancreatic Cancer


Benefits of Mejopac 100 – Paclitaxel Protein Bound Particles Suspension for Injection

In Breast Cancer:


Mejopac 100 helps in the treatment of breast cancer, either alone or in combination with other medications or treatments like chemotherapy. It alleviates symptoms associated with breast cancer, such as breast lumps, bloody discharge from the nipples, or changes in the shape or texture of the breast. Mejopac 100 works by killing or inhibiting the growth of cancer cells and preventing their multiplication. If any side effects concern you, discuss them with your doctor.

Side Effects of Mejopac 100 – Paclitaxel Protein Bound Particles Suspension for Injection

Most side effects are mild and usually do not require medical attention, as they tend to diminish as your body adjusts to the medication. However, consult your doctor if they persist or if you are concerned about them.


Common Side Effects of Mejopac 100:


  • Nausea
  • Vomiting
  • Weakness
  • Low blood platelets
  • Rash
  • Upper respiratory tract infection
  • Urinary tract infection
  • Bleeding
  • Anemia (low red blood cell count)
  • Flushing (sense of warmth in the face, ears, neck, and trunk)
  • Hair loss
  • Decreased blood pressure
  • Peripheral neuropathy (tingling and numbness in feet and hands)
  • Diarrhea
  • Decreased white blood cell count (neutrophils)

How to Use Mejopac 100 for Injection


Your doctor or nurse will administer this medicine to you. Please do not self-administer.

How Mejopac 100 for Injection Works

Mejopac 100 Suspension for Injection is an anticancer medication. It functions by interfering with the microtubule structures that assist cancer cells in dividing and multiplying. This action slows down the growth of cancer cells and ultimately kills them.

Description provided by mba pharmaceuticals pvt ltd.

Specifications

Composition Paclitaxel Protein Bound Particles 100 mg
Packing 1 Vial
Therapeutic Class Anticancer medication
Usage Treatment of cancer
Initial Learning Period Several weeks to months
Requires Monitoring Regular blood tests for blood count and liver function

Use cases

Category healthcare > apis > api intermediate
Primary application Treatment of cancer
Brand Not specified
Product type Product

Logistics & handling

Lead time On request
Packaging As per buyer requirement
Storage condition As recommended by supplier
Origin India
Form As listed by supplier

Commercials (this seller)

Minimum order 1 Centimetre
Lead time On request
Payment terms As per negotiated commercial agreement.
Checkout type enquiry
Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Paclitaxel Protein Bound Particles 100 mg Injection. Answers compiled from verified sellers' commercial terms and platform data.

Q: What types of cancer is Mejopac 100 effective for?
A: Mejopac 100 is effective for breast cancer, non-small cell lung cancer, and pancreatic cancer.
Q: How is Mejopac 100 administered?
A: Mejopac 100 is administered as an injection by a qualified healthcare professional.
Q: What are the common side effects of Mejopac 100?
A: Common side effects include nausea, vomiting, weakness, and low blood platelets.
Q: Is it safe to use Mejopac 100 during pregnancy?
A: Mejopac 100 is not recommended during pregnancy or breastfeeding, and effective contraception is advised during treatment.
Q: How do I know if Mejopac 100 is working?
A: It may take several weeks to months to notice the benefits. Regular medical evaluations and blood tests are essential to monitor treatment effectiveness and manage side effects.
Question not answered? Ask sellers directly — typical response within 4 hours.
Paclitaxel Protein Bound Particles 100 mg Injection
Paclitaxel Protein Bound Particles 100 mg Injection
Price on request · MOQ 1Centimetre